THE BRITISH SOCIETY FOR NANOMEDICINE
With the global benefits of nanomedicine growing each year, the British Society for Nanomedicine enables open access for industry, academia, clinicians and the general public to news and details of ongoing research throughout the UK.Scientists can also present their latest advances and highlight their work to industry and other researchers.
Financial health, per its FY2025 accounts
The accounts state that the charity's unrestricted reserves stood at £39,262 at the end of the period, which exceeds the trustees' stated prudent policy target of £5,000. The charity reported a net surplus of £7,446 for the year, with all expenditure related to conference costs supporting its key objectives.
What the accounts disclose
“Due to the nature of the Charity’s activities, the Trustees consider it prudent to hold reserves of £5,000 to underwrite future conference organisation.” — page 5
Trustees
- Professor Lewis Webb Francischair
- DR Christine Dufes
- Dr Ioanna Mela
- Dr Marco Giardiello
- Dr Maria Thanou
- Dr Rachel Townsend
- Dr Sandra Vranic
- Dr THOMAS OLIVER MCDONALD
- Professor Gavin Mark Roberts Jell
- Professor Kamalinder K Singh
- Professor Neill James Liptrott
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/07/2025 | £35k | £22k |
| 31/07/2024 | £11k | £21k |
| 31/07/2023 | £73k | £47k |
| 31/07/2022 | £2k | £2k |
| 31/07/2021 | £1k | £2k |
Common questions
Is THE BRITISH SOCIETY FOR NANOMEDICINE financially healthy?
Per its FY2025 accounts: The accounts state that the charity's unrestricted reserves stood at £39,262 at the end of the period, which exceeds the trustees' stated prudent policy target of £5,000. The charity reported a net surplus of £7,446 for the year, with all expenditure related to conference costs supporting its key objectives.